Sergei Gryaznov
Förmögenhet: 64 650 $ per 2026-05-31
Förmögenhet: 64 650 $ per 2026-05-31
Sergei M.
Gryaznov is the founder of Lynx Therapeutics, Inc. (1993).
Current job includes Chief Scientific Officer at MAIA Biotechnology, Inc. (2019 - present).
Former jobs include Chemistry Director at Geron Corp.
(2013) and Chief Technology Officer at Exicure Operating Co. Education includes graduate and doctorate degrees from Moscow State University Lomonosov.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC. 0,08 % | 2026-06-01 | 46 511 ( 0,08 % ) | 64 650 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2019-12-01 |
| Företag | Position | Slut |
|---|---|---|
| GERON CORPORATION | Företagsledare/Principal | 2013-01-01 |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Företagsledare/Principal | 1997-01-01 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Moscow State University Lomonosov
Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops cancer therapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån